Skip to main content
OpenTrials
Completed

NCT Number: NCT06918574

Breastfeeding Roadmap in Primiparous Women

The effect of the breastfeeding roadmap used in primiparous mothers on breastfeeding self-efficacy perception and breastfeeding success will be evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Necmettin Erbakan University Faculty of Medicine Hospital

Konya, Turkey (Türkiye)

About this study

The research was planned as a randomized controlled experimental study. Mothers who meet the inclusion criteria and agree to participate in the study will be assigned to the intervention and control groups according to the randomization list.

A total of 74 primiparous mothers who gave birth, 37 in the intervention group and 37 in the control group, will be included in the study.

In addition to the routine breastfeeding education given by the clinic's education nurse, the mothers in the intervention group will also receive a "Breastfeeding Roadmap" education poster prepared by the researchers, which will be hung on the wall of their rooms. The researcher will introduce the Breastfeeding Roadmap to the mothers and provide information on breastfeeding. Routine hospital breastfeeding education will receive to mothers in the control group after childbirth.

Data Collection Pre-Test; Introductory Information Form, Breastfeeding Self-Efficacy Scale Short-Form, LATCH Breastfeeding Assessment Tool will be collected within the first hour after birth (before Breastfeeding Roadmap breastfeeding education and hospital routine breastfeeding education were implemented) Post-test; Breastfeeding Self-Efficacy Scale Short-Form, LATCH Breastfeeding Assessment Tool will be collected at least two hours before mothers are discharged from the hospital (the discharge period usually varies between 24 and 48 hours).

At the end of the study, the results of the mothers in the experimental and control groups will be evaluated.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteer to participate in the study,
  • Primiparous,
  • Giving birth at 37 weeks of gestation or later,
  • No condition preventing breastfeeding,
  • No condition preventing breastfeeding in the baby,
  • At least primary school graduate,
  • Mothers aged 18 and over

Exclusion criteria

  • Those who have given birth to multiple pregnancies,
  • Those who received general anesthesia for Caesarean section,
  • Those who have any chronic disease, diagnosed mental or psychiatric illness history,
  • Those who have a history of preeclampsia, eclampsia and gestational diabetes,
  • Those whose babies are in intensive care after birth

Treatment and study plan

Breastfeeding Education with Breastfeeding Roadmap

Other

Information about the "Breastfeeding Roadmap" prepared by the researchers will be explained to the mothers in the intervention group and hung in poster rooms.

Primary outcomes

  1. Sociodemographic characteristics

    Time frame: Within the first hour after the mother's birth.

    Comparison of sociodemographic characteristics of women before the intervention with the questionnaire

  2. Breastfeeding Self-Efficacy Short Form Scale

    Time frame: Within the first hour after the mother's birth.

    Mothers whose pre-test data are collected will be assigned to intervention and control groups (Pre-test).

    The scale consists of 14 items. It is scored between 1-5 and the lowest 14 and the highest 70 points can be obtained. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

  3. Breastfeeding Self-Efficacy Short Form Scale

    Time frame: At least two hours before mothers are discharged from the hospital (the discharge period usually varies between 24 and 48 hours)

    Post-test data will be collected before mothers are discharged from the hospital (Post-test).

    The scale consists of 14 items. It is scored between 1-5 and the lowest 14 and the highest 70 points can be obtained. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

  4. LATCH Breastfeeding Assessment Tool

    Time frame: Within the first hour after the mother's birth

    Mothers whose pre-test data are collected will be assigned to intervention and control groups (pre-test).

    The scale consists of five evaluation criteria and each item is evaluated between 0-2 points. The score that can be obtained from the measurement tool can vary between 0-10. The higher the score obtained from the scale, the higher the breastfeeding success.

  5. LATCH Breastfeeding Assessment Tool

    Time frame: At least two hours before mothers are discharged from the hospital (the discharge period usually varies between 24 and 48 hours)

    Post-test data will be collected before mothers are discharged from the hospital (Post-test).

    The scale consists of five evaluation criteria and each item is evaluated between 0-2 points. The score that can be obtained from the measurement tool can vary between 0-10. The higher the score obtained from the scale, the higher the breastfeeding success.

Sponsors and collaborators

Lead sponsor

Selcuk University

Other

Registry information

Official study title

The Effect of Breastfeeding Roadmap on Breastfeeding Self-Efficacy Perception and Breastfeeding Success in Primiparous Women

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 9, 2025
Registry last updated
Jul 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.